Top Story
Sanofi to donate 100M doses of new flu vaccine
Protein Sciences' gene-based approach to vaccine development has drawn considerable support from the federal government. The government issued a $35 million contract to the vaccine company to help advance an entirely new approach to vaccine development that holds the promise of being far faster than the R&D methods currently in use. And that will give the government, and the world, a better shot at a rapid-fire response to future pandemics. ReportNews Timeline
Breaking swine flu news
Want more information on the ongoing swine flu outbreak? Get breaking news and more details here. TimelineFrom The Network
Also Noted
Swine Flu
Novartis has produced the first batch of H1N1 vaccine in Europe using cell culture production methods. But a mass stockpile won't be ready for another two months. Report
Inovio Biomedical has forged a new collaboration with the National Microbiology Laboratory of the Public Health Agency of Canada and the University of Pennsylvania to further evaluate the company's DNA vaccine candidates against swine influenza A virus. Release
Some U.S. experts say that unlike Canada, America could distribute an H1N1 vaccine without an adjuvant to boost its effectiveness. Story
Vaccine Research
Read more >>Press Releases
- GSK further extends its product portfolio in the Middle East and North Africa
- Symetis raises $21 million
- Symetis Raises $21 Million
- Lu AA24530 shows positive results in major depressive disorder phase II study
- Sepracor Provides Update on Clinical Trials for SEP-225289 and LUNESTA(R) Pediatrics
- Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Invest




